全球標靶定序與重定序市場

預計到 2030 年全球標靶定序和重定序市場規模將達到 228 億美元

全球標靶定序和重定序市場規模預計在2024年為74億美元，預計到2030年將達到228億美元，2024年至2030年的複合年成長率為20.6%。作為報告分析的細分市場之一，定序預計在分析期間結束時的複合年成長率為22.8%，達到158億美元。定序市場在分析期間的複合年成長率預計為16.6%。

美國市場規模估計為 20 億美元，中國市場預期複合年成長率為 28.0%

美國標靶定序和重測序市場規模預計在2024年達到20億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到55億美元，在2024-2030年的分析期間內，複合年成長率為28.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為16.2%和18.6%。在歐洲，預計德國市場的複合年成長率約為17.3%。

全球靶向測序和重測序市場—主要趨勢和促進因素摘要

為什麼研究人員和臨床醫生優先考慮標靶定序而不是廣泛的基因組方法？

標靶定序和重測序因其能夠極其精確、高效且經濟地聚焦於特定基因組區域而被廣泛採用，成為全基因組和轉錄組測序的有力替代方案。與需要大量資料處理、儲存和解釋非必要資訊的全基因組方法不同，標靶定序使科學家能夠識別已知的疾病相關基因、熱點或突變。這種精準主導的策略在腫瘤學、罕見疾病篩檢、藥物基因組學和其他需要時間和成本敏感的測試來指導治療決策的診斷學中尤其有價值。尤其是標靶重測序，它透過聚焦於先前發現的位點，在研究個體或群體之間的基因組變異性方面發揮關鍵作用，使其成為群體遺傳學、進化生物學和突變研究的重要工具。這些方法還可以深度覆蓋選定區域，從而檢測廣泛定序可能遺漏的低頻變異。客製化基因面板的靈活性、與FFPE組織等劣化樣本的兼容性以及簡化的數據解讀工作流程，增加了對標靶策略的依賴。隨著醫療保健行業向個人化和精準醫療模式邁進，靶向測序和重測序正在為研究人員和臨床醫生提供所需的粒度、擴充性和相關性，幫助他們做出有影響力的發現和明智的臨床決策。

技術進步如何增強標靶定序能力？

定序技術、文庫製備試劑套件和生物資訊流程的快速發展顯著提高了標靶定序和重定序工作流程的準確性、速度和靈活性。新一代定序 (NGS) 平台現在提供超深度定序功能，具有更高的通量、更低的錯誤率和更短的運行時間，使研究人員能夠以單鹼基解析度探究特定的基因組區域。雜交捕獲和基於擴增子的富集技術正變得越來越複雜，即使在低輸入或受損樣本中也能提供高特異性和最小的脫靶雜訊。探針設計、索引和條碼的改進現在允許在單次運行中連接複用數百個樣本，而不會影響資料品質。新興的長讀技術補充了短讀方法，提高了目標區域中結構變異、重複區域和複雜基因組重排的解析度。自動化工作流程和液體處理機器人正在提高可重複性並最大限度地減少人為錯誤。在數據分析方面，機器學習演算法和人工智慧驅動的註釋平台正在改變變異的調用、解讀和視覺化，促進臨床相關變異的識別並確定可操作結果的優先順序。雲端基礎的儲存和分析解決方案也日益整合，實現了即時協作、法規遵循以及跨實驗室的高效資料共用。此外，靶向測序面板正在針對特定疾病應用進行客製化，包括腫瘤學、心臟遺傳學、神經遺傳學和感染疾病，提供適用的診斷和研究工具。這些技術進步擴展了標靶定序的多功能性，它將繼續成為研究和臨床基因組學的基礎技術。

靶向測序和重測序應用在哪裡以及使用案例如何演變？

標靶定序和重測序的應用範圍廣泛，從臨床診斷和藥物基因組學到農業基因組學和演化生物學。在醫療保健領域，標靶定序面板廣泛應用於腫瘤學，以識別驅動突變、指導標靶治療和監測治療抗藥性。基於液態切片的靶向檢測面板正越來越受歡迎，用於非侵入性癌症監測和微量殘存疾病的檢測。在罕見疾病診斷中，特別是對於遺傳異質性疾病，標靶重測序使臨床醫生能夠專注於一組精選的基因，以提高診斷產量，同時控制成本。感染疾病專家正在使用標靶定序來監測病原體的進化、抗藥性基因的傳播和追蹤疫情。在藥物基因組學中，針對藥物代謝基因的面板被用於預測患者的反應和製定個人化治療計劃。除了人類健康之外，動植物育種者還使用靶向測序來識別和追蹤理想性狀、支持標記輔助選擇和保護生物多樣性。在微生物生態學，研究人員正在利用特定 16S、18S 或 ITS 區域的靶向重測序來分析複雜群落並研究微生物相互作用。群體遺傳學家正在使用靶向重測序來研究不同群體之間的祖先譜系、疾病易感性以及基因-環境相互作用。標靶化方法在法醫學中的效用也正在不斷擴展，其中客製化面板用於身份確認、親屬關係分析和混合物鑑定。隨著監管標準的不斷發展以及新一代測序 (NGS) 逐漸融入常規實踐，靶向測序和重測序正成為實驗室和機構的首選解決方案，旨在最大限度地提高科研產量，同時最大限度地降低成本和複雜性。

是什麼推動了標靶定序和重測序市場的全球成長？

全球標靶定序和重定序市場的發展受到多種因素的驅動，包括精準醫療需求的不斷成長、定序技術的進步、慢性病和遺傳疾病負擔的加重，以及對經濟高效的基因組解決方案的需求。世界各地的醫療保健系統都優先考慮快速、準確和臨床相關的診斷，而靶向檢測組在提供這些診斷方面具有獨特的優勢。癌症、罕見疾病和感染疾病率的上升推動了對快速、可靠的檢測的需求，指南治療和控制策略。越來越多的監管部門核准和對基於檢測組的診斷的報銷支持，正在推動主要市場的臨床應用。在研究方面，政府和私人對基因組學的投資不斷增加，推動了標靶化方法在生物庫、大型隊列研究和精密農業舉措等高影響力計劃中的使用。配備預檢驗檢測組、自動化製備試劑套件和整合分析軟體的承包定序解決方案的出現，正在降低小型實驗室和分散設施的進入門檻。產學合作正在加速疾病特異性基因組合開發的創新，確保提供穩定且客製化的解決方案，以滿足新興的臨床和研究需求。此外，隨著全球日益關注資料安全和合規性，雲端基礎的平台和安全的資料管道正在促進標靶定序在法規環境中的應用。靶向測序和重測序的可擴展性、經濟實惠性以及日益廣泛的應用範圍將繼續推動該市場的快速擴張，為跨學科領域提供有針對性的、高價值的基因組學洞察。

部分

技術（定序、重定序）、類型（基於 DNA 的標靶定序、基於 RNA 的標靶定序）、應用（臨床應用、植物和動物科學、藥物開發、其他）、最終用途（醫院和診所、學術研究、其他）

受訪公司範例

• Agilent Technologies, Inc.
• Azenta Life Sciences（GENEWIZ）
• BGI Genomics
• Bio-Rad Laboratories, Inc.
• CD Genomics
• CosmosID
• DNASTAR, Inc.
• Element Biosciences
• Eurofins Genomics
• F. Hoffmann-La Roche Ltd
• GATC Biotech AG
• Genomatix GmbH
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Macrogen, Inc.
• New England Biolabs
• Novogene Corporation
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California, Inc.
• Paragon Genomics
• PerkinElmer, Inc.
• PierianDx

人工智慧整合

全球產業分析師正在利用可操作的專家內容和人工智慧工具改變市場和競爭情報。

Global Industry Analysts 並未遵循典型的 LLM 或特定產業的 SLM查詢，而是建立了一個從全球專家收集的內容庫，其中包括影片錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Targeted Sequencing and Resequencing Market to Reach US$22.8 Billion by 2030

The global market for Targeted Sequencing and Resequencing estimated at US$7.4 Billion in the year 2024, is expected to reach US$22.8 Billion by 2030, growing at a CAGR of 20.6% over the analysis period 2024-2030. Sequencing, one of the segments analyzed in the report, is expected to record a 22.8% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Re-Sequencing segment is estimated at 16.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 28.0% CAGR

The Targeted Sequencing and Resequencing market in the U.S. is estimated at US$2.0 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$5.5 Billion by the year 2030 trailing a CAGR of 28.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.2% and 18.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 17.3% CAGR.

Global Targeted Sequencing and Resequencing Market - Key Trends & Drivers Summarized

Why Are Researchers and Clinicians Prioritizing Targeted Sequencing Over Broader Genomic Approaches?

Targeted sequencing and resequencing are gaining widespread adoption as powerful alternatives to whole-genome and transcriptome sequencing due to their ability to focus on specific genomic regions of interest with exceptional accuracy, efficiency, and cost-effectiveness. Unlike whole-genome approaches, which require significant data processing, storage, and interpretation of vast amounts of non-essential information, targeted sequencing enables scientists to zero in on known disease-associated genes, hotspots, or mutations-yielding clinically actionable results faster and with less computational burden. This precision-driven strategy is especially valuable in diagnostics, where time-sensitive and cost-sensitive tests are needed to inform therapeutic decision-making, such as in oncology, rare disease screening, and pharmacogenomics. Targeted resequencing, in particular, plays a vital role in studying genomic variability among individuals or populations by focusing on previously identified loci, making it an essential tool for population genetics, evolutionary biology, and mutational studies. These approaches also offer deep coverage of selected regions, enabling the detection of low-frequency variants that might be missed with broader sequencing. The flexibility to customize gene panels, the compatibility with degraded samples such as FFPE tissues, and the streamlined data interpretation workflows are further contributing to the increasing reliance on targeted strategies. As the healthcare sector moves toward personalized and precision medicine models, targeted sequencing and resequencing are providing the granularity, scalability, and relevance that researchers and clinicians need to drive impactful discoveries and informed clinical decisions.

How Are Advancements in Technology Enhancing the Capabilities of Targeted Sequencing?

The rapid evolution of sequencing technologies, library preparation kits, and bioinformatics pipelines is significantly enhancing the accuracy, speed, and flexibility of targeted sequencing and resequencing workflows. Next-generation sequencing (NGS) platforms now offer ultra-deep sequencing capabilities with higher throughput, lower error rates, and shorter run times, allowing researchers to interrogate specific genomic regions at single-nucleotide resolution. Hybrid capture and amplicon-based enrichment techniques are becoming more refined, offering high specificity and minimal off-target noise, even in low-input or damaged samples. Improvements in probe design, indexing, and barcoding are enabling the multiplexing of hundreds of samples in a single run without compromising data quality. Emerging long-read technologies are complementing short-read methods, allowing for better resolution of structural variants, repeat regions, and complex genomic rearrangements in targeted regions. Automated workflows and liquid-handling robotics are improving reproducibility and minimizing human error, which is particularly valuable in clinical and high-throughput research labs. On the data analysis side, machine learning algorithms and AI-powered annotation platforms are transforming variant calling, interpretation, and visualization-making it easier to identify clinically relevant mutations and prioritize actionable results. Cloud-based storage and analysis solutions are also becoming more integrated, enabling real-time collaboration, regulatory compliance, and efficient data sharing across research institutions. Additionally, targeted panels are being tailored for specific disease applications, including oncology, cardiogenetics, neurogenetics, and infectious diseases, providing fit-for-purpose diagnostic and research tools. These technological strides are expanding the versatility of targeted sequencing, ensuring it remains a foundational technique in both research and clinical genomics.

Where Is Targeted Sequencing and Resequencing Being Applied, and How Are Use Cases Evolving?

The applications of targeted sequencing and resequencing span a growing array of disciplines, from clinical diagnostics and pharmacogenomics to agricultural genomics and evolutionary biology. In healthcare, targeted sequencing panels are being widely used in oncology to identify driver mutations, guide targeted therapies, and monitor treatment resistance. Liquid biopsy-based tests using targeted panels are gaining traction for non-invasive cancer monitoring and minimal residual disease detection. In rare disease diagnosis, especially for genetically heterogeneous conditions, targeted resequencing enables clinicians to focus on curated sets of genes to improve diagnostic yield while keeping costs manageable. Infectious disease specialists use targeted sequencing to monitor pathogen evolution, resistance gene spread, and outbreak tracking. In pharmacogenomics, panels targeting drug metabolism genes are used to predict patient responses and personalize therapy plans. Beyond human health, plant and animal breeders use targeted sequencing to identify and track desirable traits, support marker-assisted selection, and protect biodiversity. In microbial ecology, researchers use targeted resequencing of specific 16S, 18S, or ITS regions to profile complex communities and study microbial interactions. Population geneticists use targeted resequencing to study ancestral lineages, disease predisposition, and gene-environment interactions across different cohorts. The utility of targeted approaches is also expanding in forensics, where customized panels are used for identity verification, kinship analysis, and mixture resolution. As regulatory standards evolve and NGS becomes more embedded in routine practice, targeted sequencing and resequencing are becoming go-to solutions for laboratories and organizations aiming to maximize scientific yield while minimizing costs and complexity.

What’s Fueling the Global Growth of the Targeted Sequencing and Resequencing Market?

The global market for targeted sequencing and resequencing is being propelled by a combination of rising demand for precision medicine, improvements in sequencing technology, the growing burden of chronic and genetic diseases, and the need for cost-effective genomic solutions. Healthcare systems worldwide are prioritizing rapid, accurate, and clinically relevant diagnostics, which targeted panels are uniquely positioned to deliver. The rising incidence of cancer, rare disorders, and infectious disease outbreaks is pushing demand for fast, high-confidence testing that can guide treatment and containment strategies. Regulatory approvals of panel-based diagnostics and increasing reimbursement support are encouraging clinical adoption across major markets. In the research sector, expanding government and private investment in genomics is supporting the use of targeted methods for high-impact projects, such as biobanking, large cohort studies, and precision agriculture initiatives. The emergence of turnkey sequencing solutions-complete with pre-validated panels, automated prep kits, and integrated analysis software-is lowering the barrier to entry for smaller labs and decentralized facilities. Academic-industrial partnerships are accelerating innovation in disease-specific panel development, ensuring a steady pipeline of relevant solutions tailored to emerging clinical and research needs. Additionally, as global emphasis on data security and compliance grows, cloud-based platforms and secure data pipelines are making it easier to deploy targeted sequencing in regulated environments. The scalability, affordability, and growing range of applications for targeted sequencing and resequencing ensure that this market will continue expanding rapidly-anchored in its ability to deliver focused, high-value genomic insights across disciplines.

SCOPE OF STUDY:

The report analyzes the Targeted Sequencing and Resequencing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technology (Sequencing, Re-Sequencing); Type (DNA-based targeted sequencing, RNA-based targeted sequencing); Application (Clinical application, Plant & animal sciences, Drug development, Others); End-Use (Hospitals & Clinics, Academic research, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Agilent Technologies, Inc.
• Azenta Life Sciences (GENEWIZ)
• BGI Genomics
• Bio-Rad Laboratories, Inc.
• CD Genomics
• CosmosID
• DNASTAR, Inc.
• Element Biosciences
• Eurofins Genomics
• F. Hoffmann-La Roche Ltd
• GATC Biotech AG
• Genomatix GmbH
• Illumina, Inc.
• Integrated DNA Technologies, Inc.
• Macrogen, Inc.
• New England Biolabs
• Novogene Corporation
• Oxford Nanopore Technologies plc
• Pacific Biosciences of California, Inc.
• Paragon Genomics
• PerkinElmer, Inc.
• PierianDx

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Targeted Sequencing and Resequencing - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Demand for Focused Genomic Insights Throws the Spotlight on Targeted Sequencing and Resequencing in Clinical and Research Applications
  • Rising Adoption of Precision Medicine Propels Utilization of Disease-Specific Gene Panels for Targeted Genetic Analysis
  • Need for Cost-Effective and Scalable Sequencing Solutions Strengthens the Business Case for Targeted Approaches Over Whole Genome Methods
  • Expansion of Rare Disease Diagnostics and Carrier Screening Drives Growth in Customizable Resequencing Panels
  • Integration with Liquid Biopsy and Minimal Residual Disease Testing Accelerates Use of Targeted Assays in Oncology
  • Technological Advancements in Library Preparation and Target Enrichment Enhance Efficiency and Coverage Depth
  • Increasing Application in Infectious Disease Surveillance Expands the Addressable Market for Targeted RNA Sequencing
  • Wider Adoption of Pharmacogenomics Testing Drives Routine Use of Targeted Sequencing in Personalized Therapy Selection
  • Cloud-Based Data Analysis and Bioinformatics Tools Streamline Workflow Integration for Clinical and Research Labs
  • Academic and Translational Research Initiatives Sustain Demand for Targeted Resequencing in Population and Cohort Studies
  • Emergence of Multi-Omic and Single-Cell Platforms Drives Incorporation of Targeted Genomics in Systems Biology Research
  • Global Expansion of Genomic Biobanks and Precision Health Initiatives Fuels High-Throughput Demand for Targeted Resequencing Applications
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Targeted Sequencing and Resequencing Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Targeted Sequencing and Resequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Re-Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Re-Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Re-Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for DNA-based targeted sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for DNA-based targeted sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for DNA-based targeted sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for RNA-based targeted sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for RNA-based targeted sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for RNA-based targeted sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Clinical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Clinical Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Clinical Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Plant & Animal Sciences by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Plant & Animal Sciences by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Plant & Animal Sciences by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 38: USA Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• JAPAN
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• CHINA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: China 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• EUROPE
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Targeted Sequencing and Resequencing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• FRANCE
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 101: France Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: France 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• GERMANY
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Germany 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Italy 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 137: UK Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: UK 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Spain 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Russia 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Australia 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• INDIA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 212: India Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: India 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: South Korea 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Targeted Sequencing and Resequencing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Argentina 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Brazil 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Mexico 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Targeted Sequencing and Resequencing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Iran 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Israel 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: UAE 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030
• AFRICA
  • Targeted Sequencing and Resequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Targeted Sequencing and Resequencing by Technology - Sequencing and Re-Sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Targeted Sequencing and Resequencing by Technology - Percentage Breakdown of Value Sales for Sequencing and Re-Sequencing for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Targeted Sequencing and Resequencing by End-Use - Academic Research, Other End-Uses and Hospitals & Clinics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Targeted Sequencing and Resequencing by End-Use - Percentage Breakdown of Value Sales for Academic Research, Other End-Uses and Hospitals & Clinics for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Targeted Sequencing and Resequencing by Type - DNA-based targeted sequencing and RNA-based targeted sequencing Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Targeted Sequencing and Resequencing by Type - Percentage Breakdown of Value Sales for DNA-based targeted sequencing and RNA-based targeted sequencing for the Years 2015, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Targeted Sequencing and Resequencing by Application - Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 397: Africa 15-Year Perspective for Targeted Sequencing and Resequencing by Application - Percentage Breakdown of Value Sales for Clinical Application, Plant & Animal Sciences, Drug Development and Other Applications for the Years 2015, 2025 & 2030

IV. COMPETITION